Yahoo has won a court fight that could help the public learn more about the government’s efforts to obtain data from Internet users.
The U.S. Foreign Intelligence Surveillance Court, which reviews government requests to spy on individuals, ruled Monday that information should be made public about a 2008 case that ordered Yahoo Inc. to turn over customer data.
The order requires the government to review which portions of the opinion, briefs and arguments can be declassified and report back to the court by July 29.
The government sought the information from Yahoo under the National Security Agency’s PRISM data-gathering program. Details of the secret program were disclosed by former NSA contractor Edward Snowden, who has fled the U.S.
The program came to light in early June after The Washington Post and Guardian newspapers published documents provided by Snowden. It allows the NSA to reach into the data streams of U.S. companies such as Yahoo, Facebook Inc., Microsoft Corp., Google Inc. and others, and grab emails, video chats, pictures and more. U.S. officials have said the program is narrowly focused on foreign targets, and technology companies say they turn over information only if required by court order.
Yahoo requested in court papers filed June 14 to have the information about the 2008 case unsealed. A Yahoo spokeswoman hailed Monday’s decision and said the company believes it will help inform public discussion about the U.S. government’s surveillance programs.
The government hasn’t taken a position on whether details of the case should be published as long as it’s allowed to review the documents before publication in order to redact classified information, according to the court order.
Mark Rumold, a staff attorney at the Electronic Frontier Foundation specializing in electronic surveillance and national security issues, called the ruling incremental and said he was reserving judgment until the case details are actually released.
“It remains to be seen how forthcoming (the government) will be,” Rumold said. “The administration has said they want a debate about the propriety of the surveillance, but they haven’t really provided information to inform that debate. So declassifying these opinions is a very important place to start.”
The unsealing of such secret rulings is not unprecedented, but it is rare. The last time that happened, Rumold said, was in 2002, in a case regarding the Patriot Act.
New FDA Rules To Take Effect For TV Drug Commercials
Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look: New rules require drugmakers to be clearer and more direct when explaining their medications' risks and side effects.
The U.S. Food and Drug Administration spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay or distract viewers from risk information.
Many companies have already adopted the rules, which become binding Nov. 20. But while regulators were drafting them, a new trend emerged: thousands of pharma influencers pushing drugs online with little oversight. A new bill in Congress would compel the FDA to more aggressively police such promotions on social media platforms.
"Some people become very attached to social media influencers and ascribe to them credibility that, in some cases, they don't deserve," said Tony Cox, professor emeritus of marketing at Indiana University.
Still, TV remains the industry's primary advertising format, with over $4 billion spent in the past year, led by blockbuster drugs like weight-loss treatment Wegovy, according to ispot.tv, which tracks ads.
Simpler language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing their drugs, without medical jargon, distracting visuals or audio effects. A 2007 law directed the FDA to ensure that drug risk information appears "in a clear, conspicuous and neutral manner."
FDA has always required that ads give a balanced picture of both benefits and risks, a requirement that gave rise to those long, rapid-fire lists of side effects parodied on shows like "... Read More